Truqap is actually a kinase inhibitor that works by blocking pathways that assist the cancer cells endure and improve, so cuts down most cancers expansion. Truqap is from a category of medicines identified as an AKT inhibitor. Truqap gained FDA approval on November 17, 2023, following good final results from https://marjaneyf555zla1.csublogs.com/profile